Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Cited In for PubMed (Select 15590763)


The Clinical Utility of SUDOSCAN in Chronic Kidney Disease in Chinese Patients with Type 2 Diabetes.

Luk AO, Fu WC, Li X, Ozaki R, Chung HH, Wong RY, So WY, Chow FC, Chan JC.

PLoS One. 2015 Aug 13;10(8):e0134981. doi: 10.1371/journal.pone.0134981. eCollection 2015.


Implantable Cardioverter-Defibrillators in Patients with CKD: A Propensity-Matched Mortality Analysis.

Nakhoul GN, Schold JD, Arrigain S, Harb SC, Jolly S, Wilkoff BL, Nally JV Jr, Navaneethan SD.

Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1119-27. doi: 10.2215/CJN.11121114. Epub 2015 Jun 25.


Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.

Athyros VG, Tziomalos K, Katsiki N, Doumas M, Karagiannis A, Mikhailidis DP.

World J Gastroenterol. 2015 Jun 14;21(22):6820-34. doi: 10.3748/wjg.v21.i22.6820. Review.


Importance of simultaneous evaluation of multiple risk factors for hemodialysis patients' mortality and development of a novel index: dialysis outcomes and practice patterns study.

Kanda E, Bieber BA, Pisoni RL, Robinson BM, Fuller DS.

PLoS One. 2015 Jun 1;10(6):e0128652. doi: 10.1371/journal.pone.0128652. eCollection 2015.


Predicting one-year mortality in peritoneal dialysis patients: an analysis of the china peritoneal dialysis registry.

Cao XY, Zhou JH, Cai GY, Tan NN, Huang J, Xie XC, Tang L, Chen XM.

Int J Med Sci. 2015 May 1;12(4):354-61. doi: 10.7150/ijms.11694. eCollection 2015.


Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients.

Szeto CC, Kwan BC, Chow KM, Kwok JS, Lai KB, Cheng PM, Pang WF, Ng JK, Chan MH, Lit LC, Leung CB, Li PK.

PLoS One. 2015 May 26;10(5):e0125162. doi: 10.1371/journal.pone.0125162. eCollection 2015.


Decade-long trends (1999-2009) in the characteristics, management, and hospital outcomes of patients hospitalized with acute myocardial infarction with prior diabetes and chronic kidney disease.

Tisminetzky M, McManus DD, Dor A, Miozzo R, Yarzebski J, Gore JM, Goldberg RJ.

Int J Nephrol Renovasc Dis. 2015 May 5;8:41-51. doi: 10.2147/IJNRD.S78749. eCollection 2015.


Heart failure in a cohort of patients with chronic kidney disease: the GCKD study.

Beck H, Titze SI, Hübner S, Busch M, Schlieper G, Schultheiss UT, Wanner C, Kronenberg F, Krane V, Eckardt KU, Köttgen A; GCKD Investigators.

PLoS One. 2015 Apr 13;10(4):e0122552. doi: 10.1371/journal.pone.0122552. eCollection 2015.


Vascular calcification in predialysis CKD: common and deadly.

Chen W, Melamed ML.

Clin J Am Soc Nephrol. 2015 Apr 7;10(4):551-3. doi: 10.2215/CJN.01940215. Epub 2015 Mar 13. No abstract available.


Effect of revascularization strategy in patients with acute myocardial infarction and renal insufficiency with multivessel disease.

Park H, Hong YJ, Rhew SH, Kim SS, Jeong YW, Jeong HC, Cho JY, Jang SY, Lee KH, Park KH, Sim DS, Yoon NS, Yoon HJ, Kim KH, Park HW, Kim JH, Ahn Y, Jeong MH, Cho JG, Park JC.

Korean J Intern Med. 2015 Mar;30(2):177-90. doi: 10.3904/kjim.2015.30.2.177. Epub 2015 Feb 27.


The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial.

Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM; Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial Investigators.

Clin J Am Soc Nephrol. 2015 May 7;10(5):791-9. doi: 10.2215/CJN.07730814. Epub 2015 Feb 20.


Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.

Ritter CS, Zhang S, Delmez J, Finch JL, Slatopolsky E.

Kidney Int. 2015 Jun;87(6):1141-52. doi: 10.1038/ki.2015.22. Epub 2015 Feb 18.


Diagnosis and treatment of incident hypertension among patients with diabetes: a U.S. multi-disciplinary group practice observational study.

Wallace ML, Magnan EM, Thorpe CT, Schumacher JR, Smith MA, Johnson HM.

J Gen Intern Med. 2015 Jun;30(6):768-76. doi: 10.1007/s11606-015-3202-0.


Racial and ethnic differences in mortality and cardiovascular events among patients with end-stage renal disease due to lupus nephritis.

Gómez-Puerta JA, Feldman CH, Alarcón GS, Guan H, Winkelmayer WC, Costenbader KH.

Arthritis Care Res (Hoboken). 2015 Jan 26. doi: 10.1002/acr.22562. [Epub ahead of print]


Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.

Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, Andreucci VE, Fukagawa M, Frimat L, Mendelssohn DC, Port FK, Pisoni RL, Robinson BM.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):98-109. doi: 10.2215/CJN.12941213. Epub 2014 Dec 16.


Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes.

Garimella PS, Hirsch AT.

Adv Chronic Kidney Dis. 2014 Nov;21(6):460-71. doi: 10.1053/j.ackd.2014.07.005. Epub 2014 Oct 24. Review.


Diabetic kidney disease: from epidemiology to clinical perspectives.

Park CW.

Diabetes Metab J. 2014 Aug;38(4):252-60. doi: 10.4093/dmj.2014.38.4.252. Review.


Arterial stiffness, central pressures, and incident hospitalized heart failure in the chronic renal insufficiency cohort study.

Chirinos JA, Khan A, Bansal N, Dries DL, Feldman HI, Ford V, Anderson AH, Kallem R, Lash JP, Ojo A, Schreiber M, Sheridan A, Strelsin J, Teal V, Roy J, Pan Q, Go AS, Townsend RR; CRIC Study Investigators; CRIC Study Investigators.

Circ Heart Fail. 2014 Sep;7(5):709-16. doi: 10.1161/CIRCHEARTFAILURE.113.001041. Epub 2014 Jul 24.


The association between individual and combined components of metabolic syndrome and chronic kidney disease among African Americans: the Jackson Heart Study.

Mendy VL, Azevedo MJ, Sarpong DF, Rosas SE, Ekundayo OT, Sung JH, Bhuiyan AR, Jenkins BC, Addison C.

PLoS One. 2014 Jul 3;9(7):e101610. doi: 10.1371/journal.pone.0101610. eCollection 2014.


Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis.

Lee JJ, Lin MY, Chang JS, Hung CC, Chang JM, Chen HC, Yu ML, Hwang SJ.

PLoS One. 2014 Jun 27;9(6):e100790. doi: 10.1371/journal.pone.0100790. eCollection 2014.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk